Sigong Tech Co., Ltd. (KOSDAQ:020710)

Verve Therapeutics Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 29, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	74,227	76,302	82,931	79,979	128,730	95,303
Market Cap Growth	-19.73%	-7.99%	3.69%	-37.87%	35.08%	2.17%
Enterprise Value	32,272	31,677	45,446	45,305	85,375	55,826
Last Close Price	3935.00	4045.00	4215.08	3989.69	6250.05	4700.11
PE Ratio	2.14	2.50	9.97	11.55	45.43	18.19
PS Ratio	0.44	0.52	0.62	0.80	1.39	0.92
PB Ratio	0.48	0.48	0.63	0.64	1.12	0.85
P/TBV Ratio	0.49	0.49	0.64	0.66	1.14	0.86
P/FCF Ratio	17.88	4.06	14.76	-	-	7.81
P/OCF Ratio	13.51	3.82	11.40	-	-	7.56
EV/Sales Ratio	0.19	0.22	0.34	0.45	0.92	0.54
EV/EBITDA Ratio	0.91	3.71	5.67	-	183.70	9.30
EV/EBIT Ratio	0.98	5.03	8.10	-	-	11.56
EV/FCF Ratio	7.77	1.69	8.09	-	-	4.58
Debt / Equity Ratio	-	0.06	0.06	0.04	0.01	0.01
Debt / EBITDA Ratio	-	1.07	0.91	-	2.79	0.11
Debt / FCF Ratio	-	0.49	1.30	-	-	0.06
Asset Turnover	0.87	0.73	0.80	0.63	0.60	0.67
Inventory Turnover	1071.20	1290.98	690.55	604.56	620.78	495.14
Quick Ratio	0.85	1.25	1.47	1.45	1.55	1.44
Current Ratio	1.73	1.59	1.89	1.64	1.84	1.57
Return on Equity (ROE)	24.64%	21.05%	6.49%	5.80%	2.49%	4.74%
Return on Assets (ROA)	3.45%	1.95%	2.07%	-2.05%	-0.39%	1.94%
Return on Capital (ROIC)	4.80%	2.57%	2.61%	-2.65%	-0.52%	2.72%
Return on Capital Employed (ROCE)	6.50%	3.70%	4.00%	-	-	4.10%
Earnings Yield	46.83%	39.94%	10.03%	8.66%	2.20%	5.50%
FCF Yield	5.59%	24.63%	6.78%	-5.81%	-1.50%	12.80%
Dividend Yield	3.07%	2.97%	-	-	-	-
Payout Ratio	-	5.00%	4.58%	14.06%	48.11%	29.66%
Buyback Yield / Dilution	0.45%	0.59%	0.23%	2.00%	-1.20%	1.43%
Total Shareholder Return	3.52%	3.56%	0.23%	2.00%	-1.20%	1.43%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.